Importantly, HK2 was demonstrated as a metabolic function-associated biomarker for detecting circulating tumour cells in the peripheral blood of lung cancer patients that showed dismal outcome and poor response to therapy [81]. This evidence concerns the gene HK2 and neoplasm.